The Florijnz Data Science Top 50 report features ENPICOM among the fastest growing Dutch companies in 2019
April 22, 2020
Florijnz Corporate Finance conducted a market research of the most prominent organizations working in the Data Science field in the Netherlands and shared their findings in the Florijnz Data Science Top 50 report. ENPICOM is proud to be recognized as one of the rapidly developing players in the dynamic Data Science market.
The scope of the research included SMEs of 5 to 250 employees founded in 2017 or earlier. These organizations were selected and ranked based on the following factors: the average turnaround growth between 2016 and 2019, the average growth in the number of employees between 2016 and 2019, and the absolute number of employees in December 2019.
Jos Lunenberg, CEO and co-founder of ENPICOM, commented: “We are honored to be recognized among the top Data Science companies of 2019. This serves as a confirmation to us and the investors that we are on the right track and our business strategies start to pay off.”
The average annual financial turnover growth of the companies featured in the report is over 35%. Moreover, despite the exceptionally tight Dutch labor market, these SMEs have been able to grow by an average of 34% in the number of employees. In addition to the investment and the recent trends in the Data Science sector, the report provides insights into the growth strategies of the top rapidly developing players in the sector.
“Get the right people on the bus. The right talent at the right moment can make a world of difference. Despite the global health crisis, we are continuing to grow at a rapid pace.” – Jos Lunenberg continued. – “Despite this crisis, we brought a new major product update to the market – the IGX Platform 2.0 has been released just a few weeks ago. This is only the beginning.”
Would you like to learn more about our innovative immunomics data handling solutions? Talk to our experts to discuss your advanced analysis needs and see how you can make the most out of your immune repertoire sequencing data today.